Sigma-Aldrich Enters Agreement with Novatia

Sigma-Genosys, a division of Sigma-Aldrich, acquires Novatia’s cutting edge Oligo HTCS system for characterization of synthetic oligonucleotides. See the complete article at Biocompare.


About this entry